The Exit Polls Show The Need To Confront COVID-19 Denial in Red America November 17, 2020 Perspective Drew Altman analyzes the exit polls in his latest Axios column. While Biden voters see COVID-19 as a top priority, Trump supporters are still largely pandemic deniers, echoing the President.
States Are Getting Ready to Distribute COVID-19 Vaccines. What Do Their Plans Tell Us So Far? November 18, 2020 Issue Brief This brief summarizes the information contained in the all available draft COVID-19 vaccination plans submitted by states to the CDC, focusing in particular in critical areas such as identifying critical/priority populations, identifying and recruiting providers to administer vaccines, the completeness of state-level vaccine data collection and reporting systems, and communication plans. States report widely varying levels of progress.
This Week in Coronavirus: November 6 to November 12 November 13, 2020 Blog During the 43rd week since the first coronavirus case appeared in the United States, there was an increase of almost 1 million confirmed cases between Nov. 5 and 12. Approximately 7,000 confirmed deaths in the past week brought the total in the United States to 242,400.
Analysis Examines How States Can Use Medicaid Programs to Facilitate Access to Vaccines for Low-Income Children November 19, 2021 News Release As states expand COVID-19 vaccination efforts to reach newly eligible children ages 5 to 11, a new KFF analysis highlights several tools state Medicaid programs have at their disposal to increase access to, and take up of, vaccines among lower-income children. Among the key findings: States can request Medicaid administrative…
The Legal Battle Against Federal Vaccine Mandates November 18, 2021 Slide Twenty-seven states have joined lawsuits challenging at least one aspect of the Biden administration’s vaccination requirements, but the vast majority are part of multiple lawsuits.
Medicaid Policy Approaches to Facilitating Access to Vaccines for Low-Income Children November 18, 2021 Blog Following the recent US Food & Drug Administration’s (FDA) authorization and the Centers for Disease Control and Prevention’s (CDC) recommendation, children ages 5-11 are now eligible to receive Pfizer-BioNTech’s COVID-19 vaccine. There may be unique challenges to vaccinating young children, particularly those from low-income families who may face additional barriers to access. State Medicaid programs and Medicaid managed care plans are looking at a range of policy options to facilitate access to vaccines for young, low-income children.
Unvaccinated Adults are Now More Than Three Times as Likely to Lean Republican than Democratic November 16, 2021 News Release A new KFF COVID-19 Vaccine Monitor analysis finds that Republicans and Republican leaning independents, who represent 41% of adults, now make up 60% of the adult unvaccinated population across the country and that political partisanship is a stronger predictor of whether someone is vaccinated than any demographic factor measured. While…
KFF COVID-19 Vaccine Monitor: The Increasing Importance of Partisanship in Predicting COVID-19 Vaccination Status November 16, 2021 Poll Finding This analysis shows that as COVID-19 vaccination rates have increased over time, Republicans make up an increasingly disproportionate share of those who remain unvaccinated and that political partisanship is a stronger predictor of whether someone is vaccinated than demographic factors such as age, race, level of education, or insurance status.
KFF COVID-19 Vaccine Monitor: Views On The U.S. Role In Global Vaccine Distribution November 5, 2021 Poll Finding This report finds the public is generally supportive of U.S. distribution of vaccines internationally, though more likely to prefer the U.S. playing a major role versus a leading one, and there are partisan differences. The analysis also examines how different information affects the public’s views.
Overview of Data on Race/Ethnicity of COVID-19 Booster Shot Recipients November 5, 2021 Issue Brief This data note reviews data currently available at the federal and state level on race/ethnicity of booster shot recipients of COVID-19 vaccines.